PrEP: Meaning, HIV Prevention, Pills, Injections, and Protection

A person takes PrEP before a possible HIV exposure. The medicine builds protective drug levels in the body, making it much harder for HIV to establish an infection.

Simple examples include:

• PrEP may be taken as pills or injections.
• PrEP can protect people of different genders and sexual orientations.
• PrEP works best when taken according to medical instructions.
• PrEP does not protect against every STI.
• A person needs an HIV test before beginning PrEP.

Using PrEP is a preventive healthcare choice. It does not mean someone is irresponsible, promiscuous, or living with HIV.

• take PrEP;
• begin PrEP;
• use PrEP;
• stop PrEP;
• ask about PrEP.

Examples include:

• She decided to start PrEP.
• They discussed PrEP with a healthcare professional.
• He takes PrEP every day.

Do not normally say a PrEP when referring to the prevention method. When discussing a specific product, use phrases such as:

• a PrEP medication;
• a PrEP pill;
• a PrEP injection;
• a PrEP option.

Common Usage Patterns

The term commonly appears in phrases such as:

• daily PrEP;
• injectable PrEP;
• oral PrEP;
• event-driven PrEP;
• start PrEP;
• PrEP appointment;
• PrEP monitoring;
• PrEP for HIV prevention.

PrEP places antiretroviral medicine in the body before exposure. If HIV enters the body, the medicine interferes with processes the virus needs to copy itself and spread.

The CDC guide to preventing HIV with PrEP states that PrEP greatly reduces the chance of acquiring HIV through sex or injection-drug use when taken as prescribed.

PrEP is highly effective but not an absolute guarantee. Protection may be reduced when doses are missed, injections are late, treatment is stopped without planning, or HIV exposure occurs before sufficient protective drug levels have developed.

A person may consider PrEP when they:

• have vaginal or anal sex without consistent condom use;
• have a sexual partner whose HIV status is unknown;
• have a partner with HIV who is not known to have sustained viral suppression;
• have recently had certain bacterial STIs;
• share equipment used to inject drugs;
• have used PEP more than once;
• simply believe PrEP would help them feel safer.

Current US clinical guidance supports informing sexually active adults and adolescents about PrEP and prescribing it to people who request it after appropriate evaluation.

A person does not need to identify as belonging to a particular community or disclose every sexual detail before being allowed to ask about PrEP.

Daily Oral PrEP

Daily oral PrEP involves taking one pill each day.

Some oral medications are approved for people exposed through sex or injection-drug use. Other formulations are approved for sexual exposure but have not been approved for people whose HIV risk comes from receptive vaginal sex.

A healthcare professional should select a medication according to anatomy, type of exposure, kidney health, hepatitis B status, pregnancy considerations, other medicines, and local guidelines.

Injectable PrEP

Long-acting injectable PrEP is given by a healthcare professional at scheduled intervals.

Depending on the product, injections may be given every two months or twice yearly after the required starting doses. Long-acting options can help people who prefer not to take a daily pill.

The HIV.gov PrEP overview describes currently approved US oral and injectable options, including long-acting cabotegravir and lenacapavir.

Appointments must remain on schedule because delayed injections can reduce protection.

Event-Driven PrEP

Event-driven PrEP is taken around the time of sexual activity rather than every day.

The best-studied method is called 2-1-1 PrEP:

1. Two pills are taken 2 to 24 hours before sex.
2. One pill is taken 24 hours after the first dose.
3. One pill is taken 24 hours later.

This is an off-label use of a particular oral PrEP medication and has mainly been studied in adultcisgender men who have sex with men. It is not appropriate for every body, exposure type, medication, or schedule.

Event-driven PrEP should be discussed with a knowledgeable healthcare professional rather than attempted using general online instructions.

With daily oral PrEP, maximum protective drug levels are generally reached:

• after about seven days for receptive anal sex;
• after about 21 days for receptive vaginal sex;
• after about 21 days for injection-drug exposure.

Evidence is less certain about the exact time needed for maximum protection during insertive vaginal or anal sex.

The time needed for injectable PrEP depends on the medication and starting schedule. A healthcare professional may advise temporary additional protection while treatment begins.

This is important because PrEP alone does not provide complete HIV treatment. Starting or continuing PrEP during an unrecognized HIV infection may allow drug-resistant HIV to develop.

Monitoring may include:

• HIV testing before starting;
• repeated HIV testing during use;
• kidney-function tests for certain oral medicines;
• hepatitis B testing;
• STI screening;
• pregnancy testing when relevant;
• discussion of side effects and adherence;
• review of other medications.

People with recent fever, rash, swollen glands, sore throat, or flu-like symptoms after a possible HIV exposure should tell the clinician because these may occasionally indicate early HIV infection.

Protection depends on maintaining the correct drug schedule. Missing occasional doses may affect different forms of PrEP differently, and people should seek individualized advice rather than guessing whether they remain protected.

PrEP cannot remove HIV that entered the body before treatment began. Someone with a recent possible exposure may need PEP instead.

• PrEP is used before possible exposure.
• PEP is emergency medication started after a possible exposure.
• PEP should be started as quickly as possible and no later than 72 hours after exposure.
• PEP is generally taken for 28 days.
• A person who repeatedly needs PEP may consider PrEP for continuing protection.

PrEP should not be used as a substitute for urgent PEP evaluation following a recent unprotected exposure when protective PrEP levels were not already present.

• gonorrhea;
• chlamydia;
• syphilis;
• herpes;
• human papillomavirus;
• hepatitis C.

Condoms and other barriers can reduce the likelihood of certain STIs. Vaccination may help prevent hepatitis A, hepatitis B, and HPV when appropriate.

Regular STI screening remains important because many infections have no symptoms.

A person may use contraception and PrEP at the same time. There are no known conflicts between commonly used PrEP medicines and hormone-based birth-control methods.

PrEP may also be considered while trying to conceive, during pregnancy, or while breastfeeding or chestfeeding when HIV exposure remains possible. The safest choice depends on the medication, health history, exposure type, and local clinical guidance.

No one should stop PrEP solely because pregnancy is suspected without discussing continuing HIV risk and treatment options with a healthcare professional.

Possible temporary side effects of oral PrEP include:

• nausea;
• diarrhea;
• headache;
• tiredness;
• stomach discomfort.

Certain oral medicines may affect kidney function or bone mineral density in some people. Tenofovir-based medicines can also suppress hepatitis B, so stopping them suddenly in someone with hepatitis B may allow the infection to worsen.

Injectable PrEP may cause:

• pain or tenderness at the injection site;
• swelling;
• redness;
• headache;
• tiredness;
• nausea.

Severe, continuing, or concerning symptoms should be discussed with a healthcare professional.

• their HIV exposure has changed;
• they prefer another prevention method;
• side effects are troublesome;
• they cannot maintain the schedule;
• they are changing to another PrEP product.

PrEP protection does not disappear or develop in exactly the same way for every medication. Stopping should therefore be planned with a healthcare professional.

Long-acting injectable medicines may remain in the body at low levels for months after the last injection. Continued HIV testing and another prevention method may be needed during this period to reduce the risk of infection and drug resistance.

A partner should not:

• force someone to begin or stop PrEP;
• treat PrEP as permission for condomless sex;
• assume PrEP use means someone has many partners;
• disclose another person’s PrEP use without permission;
• pressure someone to reveal private test results publicly.

PrEP does not replace consent. Protection against HIV does not create permission for sexual activity or remove boundaries concerning condoms, contraception, partners, or specific acts.

Taking PrEP means someone has HIV.
PrEP is intended for people who test negative for HIV.

PrEP prevents every STI.
It prevents HIV but not most other STIs.

PrEP eliminates the need for HIV testing.
Regular testing is an essential part of safe PrEP use.

PrEP encourages irresponsible behavior.
Using preventive medicine is a responsible health choice.

PrEP and PEP are the same.
PrEP is taken before possible exposure, while PEP is started urgently afterward.

1. PrEP is medicine taken before possible exposure to reduce the chance of acquiring HIV.
2. PrEP is available as oral medication and long-acting injections.
3. Can PrEP protect someone from gonorrhea or syphilis?
4. A negative HIV test was required before the patient began PrEP.
5. Daily PrEP works best when taken consistently.
6. The clinician discussed whether injectable PrEP suited the patient’s needs.
7. PrEP does not replace consent, contraception, or STI screening.
8. A person who misses a PrEP injection should contact their healthcare provider.
9. Using PrEP does not reveal someone’s sexual orientation or number of partners.
10. The couple included PrEP in their shared HIV-prevention plan.

PrEP may reduce fear of HIV and give people greater control over their own protection. However, it does not prevent pregnancy or most other STIs, and it does not replace consent, communication, testing, or agreed relationship boundaries.

Accurate sexuality education presents PrEP without stigma, explains the difference between PrEP and PEP, encourages appropriate medical monitoring, and recognizes that choosing HIV prevention is a responsible act of bodily autonomy and sexual healthcare.